Form 4: LeMaitre Vascular Inc. Executive Trent G. Kamke Reports Share Transactions
SEC Form 4 Filing
Senior VP of Operations at LeMaitre Vascular, Trent G. Kamke, reports acquisition and disposal of common stock and dividend equivalent rights related to performance share units.
Summary
- On February 28, 2025, Trent G. Kamke, Senior VP of Operations at LeMaitre Vascular Inc., reported transactions involving the company's common stock.
- Kamke acquired 308 shares of common stock upon settlement of a Performance Share Unit (PSU) award granted on December 8, 2023, at a price of $0.
- He also acquired 2 shares upon release of dividend equivalent rights.
- 91 shares were withheld by the issuer to satisfy tax obligations at a price of $91.85 per share.
- Following these transactions, Kamke beneficially owns 5,293 shares of LeMaitre Vascular Inc. common stock.
- Kamke also reported the release of dividend equivalent rights related to the PSU award.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't convey any specific positive or negative sentiment about the company's performance or future prospects.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is a common practice in publicly traded companies to ensure transparency and compliance with SEC regulations.
Key Dates
| Date | Description |
|---|---|
| 2023-12-08 | Date of grant for Performance Share Unit (PSU) award |
| 2024-12-04 | Date of execution for Limited Power of Attorney |
| 2025-02-28 | Date of earliest transaction: Acquisition and disposal of shares and dividend equivalent rights |
| 2025-03-04 | Date of signature for the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.